RxDoctor Payments Data

Sanjeev Sethi, MD

Anatomic Pathology & Clinical Pathology · Rochester, MNNPI 1083694855

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $49,199 of the $52,610 with a category attached, or 93.5%. Novartis accounts for 75.8% of it on its own, with 5 other manufacturers making up the rest. Among anatomic pathology & clinical pathology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,610in general payments, 2019–2025

Across 22 payments — averaging $2391.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$40K
  • AstraZeneca$5K
  • Amgen$4K
  • Travere Therapeutics, Inc.$3K
  • Biocryst Pharmaceuticals, Inc.$637
  • Argenx US, Inc.$550

What the payments were for

  • Consulting fees$49,19994%
  • Speaking & faculty fees$2,5005%
  • Travel & lodging$2070%
  • Food & beverage$7051%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,610 in reported general payments places this provider in the 95th percentile of 92 anatomic pathology & clinical pathology providers in Minnesota.

See all anatomic pathology & clinical pathology providers in Minnesota

Medicare billing

Part B allowed, 2024
$36,794
Medicare patients
134
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →